Thrombin-induced Oxidative Stress Contributes to the Death of Hippocampal Neurons in Vivo: Role of Microglial NADPH Oxidase

Overview

Journal J Neurosci

Specialty Neurology

Date 2005 Apr 22

PMID 15843610

Citations 74

Authors

Sang-Ho Choi

Da Yong Lee

Seung Up Kim

Byung Kwan Jin

Affiliations

Soon will be listed here.

Abstract

The present study investigated whether thrombin, a potent microglial activator, can induce reactive oxygen species (ROS) generation through activation of microglial NADPH oxidase and if this may contribute to oxidative damage and consequent neurodegeneration. Seven days after intrahippocampal injection of thrombin, Nissl staining and immunohistochemistry using the neuronal-specific nuclear protein NeuN revealed a significant loss in hippocampal CA1 neurons. In parallel, thrombin-activated microglia, assessed by OX-42 and OX-6 immunohistochemistry, and ROS production, assessed by hydroethidine histochemistry, were observed in the hippocampal CA1 area in which degeneration of hippocampal neurons occurred. Reverse transcription-PCR at various time points after thrombin administration demonstrated an early and transient expression of inducible nitric oxide synthase (iNOS) and several proinflammatory cytokines. Western blot analysis and double-label immunohistochemistry showed an increase in the expression of and the localization of iNOS within microglia. Additional studies demonstrated that thrombin induced the upregulation of membrane (gp91(phox)) and cytosolic (p47(phox) and p67(phox)) components, translocation of cytosolic proteins (p47(phox), p67(phox), and Rac1) to the membrane, and p67(phox) expression of the NADPH oxidase in microglia in the hippocampus in vivo, indicating the activation of NADPH oxidase. The thrombin-induced oxidation of proteins and loss of hippocampal CA1 neurons were partially inhibited by an NADPH oxidase inhibitor and by an antioxidant. To our knowledge, the present study is the first to demonstrate that thrombin-induced neurotoxicity in the hippocampus in vivo is caused by microglial NADPH oxidase-mediated oxidative stress. This suggests that thrombin inhibition or enhancing antioxidants may be beneficial for the treatment of neurodegenerative diseases, such as Alzheimer's disease, that are associated with microglial-derived oxidative damage.

Citing Articles

Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases.

Kim S, Jung U, Kim S Antioxidants (Basel). 2025; 13(12.

PMID: 39765790 PMC: 11673141. DOI: 10.3390/antiox13121462.

Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer's Disease.

Kim S, Sharma C, Jung U, Kim S Biomedicines. 2023; 11(5).

PMID: 37239054 PMC: 10216844. DOI: 10.3390/biomedicines11051383.

Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders.

Sharma R, Kumarasamy M, Parihar V, Ravichandiran V, Kumar N CNS Neurol Disord Drug Targets. 2023; 23(5):638-655.

PMID: 37055898 DOI: 10.2174/1871527322666230412105711.

pKr-2 induces neurodegeneration upregulation of microglial TLR4 in the hippocampus of AD brain.

Kim S, Sharma C, Shin M, Kim H, Kim J, Kim S Brain Behav Immun Health. 2023; 28:100593.

PMID: 36798617 PMC: 9926212. DOI: 10.1016/j.bbih.2023.100593.

Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases.

Ishihara K, Takata K, Mizutani K Life (Basel). 2023; 13(1).

PMID: 36676170 PMC: 9866034. DOI: 10.3390/life13010221.

References

Babior B . NADPH oxidase: an update. Blood. 1999; 93(5):1464-76. View

Torreilles F, Guerin M, Torreilles J . Neurodegenerative disorders: the role of peroxynitrite. Brain Res Brain Res Rev. 1999; 30(2):153-63. DOI: 10.1016/s0165-0173(99)00014-4. View

Tammariello S, Quinn M, Estus S . NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci. 2000; 20(1):RC53. PMC: 6774145. View

Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann K, Reiser G . The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci U S A. 2000; 97(5):2264-9. PMC: 15789. DOI: 10.1073/pnas.040552897. View

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G . Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21(3):383-421. PMC: 3887148. DOI: 10.1016/s0197-4580(00)00124-x. View

Grammas P . A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging. 2000; 21(2):199-205. DOI: 10.1016/s0197-4580(00)00102-0. View

Berzin T, Zipser B, Rafii M, Yancopoulos G, Glass D, Fallon J . Agrin and microvascular damage in Alzheimer's disease. Neurobiol Aging. 2000; 21(2):349-55. DOI: 10.1016/s0197-4580(00)00121-4. View

Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T . Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun. 2000; 273(1):5-9. DOI: 10.1006/bbrc.2000.2897. View

Ryu J, Pyo H, Jou I, Joe E . Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem. 2000; 275(39):29955-9. DOI: 10.1074/jbc.M001220200. View

10.

Moller T, Hanisch U, Ransom B . Thrombin-induced activation of cultured rodent microglia. J Neurochem. 2000; 75(4):1539-47. DOI: 10.1046/j.1471-4159.2000.0751539.x. View

11.

Noh K, Koh J . Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci. 2000; 20(23):RC111. PMC: 6773049. View

12.

Beilin O, Gurwitz D, Korczyn A, Chapman J . Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities. Neuroreport. 2001; 12(11):2347-51. DOI: 10.1097/00001756-200108080-00013. View

13.

Cagnin A, Brooks D, Kennedy A, Gunn R, Myers R, Turkheimer F . In-vivo measurement of activated microglia in dementia. Lancet. 2001; 358(9280):461-7. DOI: 10.1016/S0140-6736(01)05625-2. View

14.

Heneka M, Wiesinger H, Riederer P, Feinstein D, Klockgether T . Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol. 2001; 60(9):906-16. DOI: 10.1093/jnen/60.9.906. View

15.

Benveniste E, Nguyen V, OKeefe G . Immunological aspects of microglia: relevance to Alzheimer's disease. Neurochem Int. 2001; 39(5-6):381-91. DOI: 10.1016/s0197-0186(01)00045-6. View

16.

Perry R, Collins J, Wiener H, Acton R, Go R . The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging. 2002; 22(6):873-83. DOI: 10.1016/s0197-4580(01)00291-3. View

17.

Uryu K, Laurer H, McIntosh T, Pratico D, Martinez D, Leight S . Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis. J Neurosci. 2002; 22(2):446-54. PMC: 6758680. View

18.

Coraci I, Husemann J, Berman J, Hulette C, Dufour J, Campanella G . CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am J Pathol. 2002; 160(1):101-12. PMC: 1867121. DOI: 10.1016/s0002-9440(10)64354-4. View

19.

Bal-Price A, Matthias A, Brown G . Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem. 2002; 80(1):73-80. DOI: 10.1046/j.0022-3042.2001.00675.x. View

20.

Gao H, Hong J, Zhang W, Liu B . Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 2002; 22(3):782-90. PMC: 6758500. View